Insulin price components: case studies in six low/middle-income countries by David Beran, Margaret Ewen, Richard Laing, Douglas Ball

Get full text

Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. by Margaret Ewen, Marjolein Zweekhorst, Barbara Regeer, Richard Laing

Get full text

Insulin prices, availability and affordability in 13 low-income and middle-income countries by David Beran, Margaret Ewen, Huibert-Jan Joosse, Richard Laing

Get full text

Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries by David Beran, Margaret Ewen, Mario Raviglione, Tido von Schoen-Angerer, Davide Morolla

Get full text

Essential medicines are more available than other medicines around the globe. by Yaser T Bazargani, Margaret Ewen, Anthonius de Boer, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse

Get full text

Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases by David Beran, Margaret Ewen, Christophe Perrin, Cécile Macé, Stephane Besancon, Molly Lepeska, Céline Mettraux, Andrew Gilmoor, Marina Giachino, Joanna Laurson-Doube, Janeth Tenorio Mucha, Rosalind Turkie

Get full text

Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries by David Beran, Margaret Ewen, Stephane Besancon, Beatrice Vetter, Molly Lepeska, Aida Abdraimova, Asel Dunganova, Janeth Tenorio-Mucha, Nguyen Thi Phuong Cham, Moise Nguemeni, Lachlan Oldfield, Hesty Utami Ramadaniati

Get full text